# Evaluation of the Superiority of VAsopressin Versus NOradrenaline in the Management of Patients at Risk of Kidney Failure Undergoing Cardiac Surgery With Extracorporeal Circulation

> **NCT05568160** · PHASE3 · ACTIVE_NOT_RECRUITING · sponsor: **Centre Hospitalier Universitaire Dijon** · enrollment: 840 (estimated)

## Conditions studied

- Scheduled Cardiac Surgery With Extracorporeal Circulation
- Vasoplegic Syndrome

## Interventions

- **DRUG:** Vasopressin
- **DRUG:** Norepinephrine
- **OTHER:** Collection of clinical data
- **OTHER:** Quality of Life Questionnaire EQ-5D

## Key facts

- **NCT ID:** NCT05568160
- **Lead sponsor:** Centre Hospitalier Universitaire Dijon
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2023-01-02
- **Primary completion:** 2026-03
- **Final completion:** 2026-03
- **Target enrollment:** 840 (ESTIMATED)
- **Last updated:** 2025-12-22


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05568160

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05568160, "Evaluation of the Superiority of VAsopressin Versus NOradrenaline in the Management of Patients at Risk of Kidney Failure Undergoing Cardiac Surgery With Extracorporeal Circulation". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT05568160. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*